New eye drops aim to halt blinding eye disease before It's too late
NCT ID NCT06659549
First seen Jan 27, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This study tests whether daily GAL-101 eye drops can slow the growth of geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. About 110 adults aged 55 and older with early-stage damage (not yet affecting central vision) will receive either the drug or placebo drops for up to 2 years. The goal is to see if treatment preserves sight by keeping the damage away from the center of the retina.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY OF THE MACULA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Akhali Mzera Limited
RECRUITINGTbilisi, 0162, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Bay Area Retina Associates
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Caucasus Medical Centre LLC
RECRUITINGTbilisi, 0186, Georgia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Monticelli Paradis d'Ophtalmologie
RECRUITINGMarseille, 13008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chichua Medical Centre Mzera LLC
RECRUITINGTbilisi, Georgia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cumberland Valley Retina Consultants
RECRUITINGHagerstown, Maryland, 21740, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hadassah Medical Center
RECRUITINGJerusalem, 9112001, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institute of Eye Surgery (IOES Waterford)
RECRUITINGWaterford, X91 DH9W, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medical Retina & Imaging Unit, IRCCS MultiMedica, Ospedale San Giuseppe
RECRUITINGMilan, Milano, 20123, Italy
Contact Email: •••••@•••••
Contact
-
Ophthalmological Center After S.V. Malayan
RECRUITINGYerevan, 0048, Armenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Retina-Vitreous Associates Medical Group
RECRUITINGBeverly Hills, California, 90211, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tel Aviv Medical Center
RECRUITINGTel Aviv, 6423906, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Unità di Oculistica, IRCCS Ospedale San Raffaele
RECRUITINGMilan, Milano, 20132, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universitäts-Augenklinik Bonn
RECRUITINGBonn, 53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.